LAS VEGAS, Jan. 5, 2023 /PRNewswire/ — Jackery, the global leader of innovative portable power and green outdoor energy solutions, has unveiled its most innovative portable solar generators to complement the high-end Pro family – the 3000 Pro and 1500 Pro – at CES 2023 (booth No.8943), running from January 5-8, 2023 in Las Vegas. […]
"CES 2023: Jackery Reveals the Revolutionary New Portable Solar Generators, Leading the Solar Power Generation Industry"Day: January 5, 2023
Strategic acquisition will add digital, out-of-the box payments capabilities to Duck Creek’s comprehensive suite of SaaS solutions for P&C and general insurers Boston, MA, Jan. 05, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies (NASDAQ: DCT) (“Duck Creek”), the intelligent solutions provider defining the future of property and casualty (P&C) insurance, today announced a definitive agreement […]
"Duck Creek to acquire Imburse Payments, a modern payments platform" Dr. Michael Murray, N.D. forecasts the 2023 wellness trends on the rise on iHerb’s popular blog PASADENA, Calif., Jan. 5, 2023 /PRNewswire/ — iHerb, the largest eCommerce platform, dedicated to vitamins, minerals, and supplements has tapped Dr. Michael Murray, N.D. – one of the leading authorities in dietary supplements, and natural products – to share his […]
"iHerb Top Wellness Trends in 2023" شكر ستقود المرحلة التالية من النموّ مع تسريع Securrency تسويق تكنولوجيا الأصول الرقمية القائمة على الامتثال للمؤسسات المالية الدولية واشنطن، 5 يناير 2023 / PRNewswire / – أعلنت اليوم شركة Securrency الرائدة في مجال تطوير التكنولوجيا المالية والتنظيمية القائمة على البلوك تشين عن انضمام نادين شكر إلى الشركة بمنصب الرئيسة التنفيذية اعتبارًا من 9 يناير 2023. وتتمتّع السيدة […]
"نادين شكر رئيسة تنفيذية لشركة Securrency الرائدة في مجال الابتكار في التكنولوجيا المالية" AUM302 is potentially eligible to receive a rare pediatric disease priority review voucher at the time of marketing approval SINGAPORE and BETHESDA, Md., Jan. 05, 2023 (GLOBE NEWSWIRE) — AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotech company focused on discovering and developing precision oncology therapeutics, announced today that the U.S. Food and Drug […]
"AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma"